通过专为投资者打造的一站式数据看板，全面查看 Xenon Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

3.92B

股息TTM

0.00

市盈率 TTM

-8.60

每股收益TTM

-4.71

营业收入

7.50M

净利润

-234.33M

净资产收益率

-37.53%

总资产收益率

-35.98%

Xenon Pharmaceuticals Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

-3.62%-1.11

-41.68%-1.17

-56.77%-1.31

-42.35%-1.15

-43.86%-1.07

-33.82%-0.83

-31.04%-0.84

-9.74%-0.81

-3.49%-0.75

2.70%-0.62

-12.33%-0.64

---0.73

---0.72

---0.63

---0.57

---1.49

----

营业收入

--0.00

-100.00%0.00

--0.00

--7.50M

----

--0.00

-100.00%0.00

-98.38%132.00K

-75.83%536.00K

101.15%8.77M

-27.44%3.74M

23.95%8.12M

净利润

-30.73%-110.74M

-57.27%-102.30M

-60.25%-105.26M

-44.76%-90.90M

-46.24%-84.71M

-35.71%-65.05M

-46.81%-65.69M

-29.57%-62.79M

-22.05%-57.92M

-14.87%-47.93M

-19.70%-44.74M

-30.45%-48.46M

-52.32%-47.46M

-115.41%-41.73M

-49.05%-37.38M

-146.30%-37.15M

-44.33%-31.16M

-26.27%-19.37M

-109.45%-25.08M

-75.28%-15.08M

利润率

----

---4612.13%

----

---867.29%

----

---932.56%

----

毛利率

----

--100.00%

----

--100.00%

----

--100.00%

----

利润表

营业收入

--0.00

-100.00%0.00

--0.00

--7.50M

----

--0.00

-100.00%0.00

-98.38%132.00K

-75.83%536.00K

101.15%8.77M

-27.44%3.74M

23.95%8.12M

营业利润

-30.70%-123.16M

-54.43%-112.33M

-41.68%-109.77M

-30.76%-96.34M

-36.36%-94.23M

-23.20%-72.74M

-44.29%-77.48M

-32.31%-73.68M

-24.23%-69.10M

-20.37%-59.04M

-23.92%-53.70M

-46.04%-55.68M

-83.49%-55.62M

-182.41%-49.05M

-74.45%-43.33M

-144.44%-38.13M

-34.75%-30.32M

-8.16%-17.37M

-92.20%-24.84M

-60.82%-15.60M

净利润

-30.73%-110.74M

-57.27%-102.30M

-60.25%-105.26M

-44.76%-90.90M

-46.24%-84.71M

-35.71%-65.05M

-46.81%-65.69M

-29.57%-62.79M

-22.05%-57.92M

-14.87%-47.93M

-19.70%-44.74M

-30.45%-48.46M

-52.32%-47.46M

-115.41%-41.73M

-49.05%-37.38M

-146.30%-37.15M

-44.33%-31.16M

-26.27%-19.37M

-109.45%-25.08M

-75.28%-15.08M

资产负债表

流动资产

89.08%945.87M

95.68%1.11B

-11.75%560.65M

-27.21%480.14M

-31.29%500.25M

-20.03%565.54M

-1.50%635.26M

24.22%659.64M

33.69%728.09M

32.60%707.20M

7.44%644.96M

-18.20%531.01M

-31.48%544.62M

-2.25%533.35M

7.38%600.30M

153.27%649.18M

197.95%794.80M

92.62%545.62M

207.52%559.02M

31.57%256.31M

流动负债总额

36.20%45.01M

24.31%39.81M

17.43%41.79M

29.10%38.34M

5.63%33.05M

44.13%32.03M

30.50%35.59M

20.01%29.70M

11.10%31.29M

-1.19%22.22M

20.13%27.27M

59.26%24.74M

105.00%28.16M

181.77%22.49M

58.51%22.70M

20.85%15.54M

-8.32%13.74M

-30.54%7.98M

-3.11%14.32M

-24.01%12.86M

总资产

92.17%1.30B

86.58%1.39B

-20.67%633.16M

-27.28%607.84M

-23.72%674.28M

-19.12%743.28M

-17.27%798.14M

24.56%835.90M

29.07%884.01M

27.67%919.02M

27.93%964.80M

-13.50%671.09M

-15.17%684.90M

28.99%719.87M

31.84%754.15M

193.48%775.81M

193.90%807.38M

91.99%558.06M

202.35%572.01M

32.76%264.35M

总负债

32.44%53.38M

24.59%48.99M

18.89%51.40M

26.86%48.33M

0.85%40.30M

25.53%39.32M

17.24%43.24M

10.41%38.09M

3.96%39.96M

-4.86%31.32M

12.95%36.88M

52.03%34.50M

78.08%38.44M

103.16%32.92M

48.58%32.65M

47.23%22.69M

21.77%21.59M

12.59%16.21M

23.23%21.97M

-9.89%15.41M

总权益

95.97%1.24B

90.04%1.34B

-22.94%581.76M

-29.87%559.51M

-24.89%633.98M

-20.70%703.96M

-18.65%754.90M

25.32%797.81M

30.57%844.05M

29.22%887.70M

28.61%927.92M

-15.47%636.59M

-17.73%646.46M

26.78%686.94M

31.17%721.50M

202.53%753.12M

205.78%785.79M

96.13%541.85M

220.99%550.03M

36.76%248.94M

现金流量表

经营净额

-48.51%-95.39M

-44.19%-88.90M

-49.82%-81.48M

-40.29%-71.75M

-96.56%-64.23M

-33.48%-61.65M

-31.84%-54.38M

-21.12%-51.15M

1.63%-32.68M

-34.22%-46.19M

-16.76%-41.25M

-38.91%-42.23M

-96.95%-33.22M

-86.73%-34.41M

-70.59%-35.33M

-102.59%-30.40M

-28.99%-16.87M

11.01%-18.43M

-57.92%-20.71M

-34.54%-15.01M

投资净额

-502.67%-331.24M

-1280.19%-407.28M

-36.35%62.70M

1846.01%38.53M

-25.70%82.26M

179.90%34.51M

142.11%98.50M

-95.88%1.98M

296.81%110.72M

-192.65%-43.19M

-1893.19%-233.94M

120.52%48.03M

2018.60%27.90M

195.36%46.62M

94.55%-11.74M

-1603.03%-234.10M

-83.92%1.32M

11.28%-48.89M

-598.70%-215.43M

186.37%15.57M

融资净额

-60.00%26.00K

73141.79%843.01M

836.00%113.54M

--2.36M

--65.00K

--1.15M

-96.26%12.13M

----

--0.00

5400133.33%324.01M

4121.46%29.51M

-100.00%0.00

-100.00%6.00K

-85.31%699.00K

243044.14%269.89M

-93.37%7.88M

719795.56%323.95M

--4.76M

营业收入

业务

报告期:

暂无数据

地区

报告期:

暂无数据

常见问题

Xenon Pharmaceuticals Inc的总收入是多少？



根据Xenon Pharmaceuticals Inc的FY2025财报，总收入达到了7.50M（同比变化7.50M）。

Xenon Pharmaceuticals Inc的流动资产是多少？



根据Xenon Pharmaceuticals Inc的FY2025财报，流动资产为560.65M（同比变化-11.75）。

Xenon Pharmaceuticals Inc的总资产是多少？



根据Xenon Pharmaceuticals Inc的FY2025财报，Xenon Pharmaceuticals Inc的总资产为633.16M（同比变化-20.67）。

Xenon Pharmaceuticals Inc的总负债是多少？



根据Xenon Pharmaceuticals Inc的FY2025财报，Xenon Pharmaceuticals Inc的总负债为51.40M（同比变化18.89）。

Xenon Pharmaceuticals Inc的总权益是多少？



根据Xenon Pharmaceuticals Inc的FY2025财报，Xenon Pharmaceuticals Inc的总权益为581.76M（同比变化-22.94）。

Xenon Pharmaceuticals Inc的净营业收入是多少？



根据Xenon Pharmaceuticals Inc的FY2025财报，Xenon Pharmaceuticals Inc的净营业收入为-373.07M（同比变化-33.57）。

Xenon Pharmaceuticals Inc的净投资是多少？



根据Xenon Pharmaceuticals Inc的FY2025财报，Xenon Pharmaceuticals Inc的净投资为218.00M（同比变化32.12）。

Xenon Pharmaceuticals Inc的净融资是多少？



根据Xenon Pharmaceuticals Inc的FY2025财报，Xenon Pharmaceuticals Inc的净融资为117.11M（同比变化865.48）。

Xenon Pharmaceuticals Inc的每股收益（EPS）是多少？



根据Xenon Pharmaceuticals Inc的FY2025财报，每股收益（EPS）为-4.36（同比变化-45.09）。

Xenon Pharmaceuticals Inc的净利润是多少？



根据Xenon Pharmaceuticals Inc的FY2025财报，净利润为-345.91M（同比变化-47.62）。

Xenon Pharmaceuticals Inc的股东权益回报率（ROE）是多少？



根据Xenon Pharmaceuticals Inc的FY2025财报，股东权益回报率（ROE）为-51.76（同比变化-85.85）。

Xenon Pharmaceuticals Inc的资产回报率（ROA）是多少？



根据Xenon Pharmaceuticals Inc的FY2025财报，资产回报率（ROA）为-48.34（同比变化-81.82）。

Xenon Pharmaceuticals Inc的营业利润是多少？



根据Xenon Pharmaceuticals Inc的FY2025财报，营业利润为-373.07M（同比变化-33.57）。